Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 09, 2023

BUY
$418.69 - $503.0 $222,324 - $267,093
531 Added 56.91%
1,464 $701,000
Q3 2022

Nov 14, 2022

BUY
$412.59 - $563.26 $9,076 - $12,391
22 Added 2.41%
933 $389,000
Q2 2022

Aug 16, 2022

BUY
$463.67 - $597.16 $6,955 - $8,957
15 Added 1.67%
911 $451,000
Q1 2022

May 04, 2022

BUY
$524.57 - $735.42 $29,375 - $41,183
56 Added 6.67%
896 $505,000
Q4 2021

Feb 07, 2022

BUY
$708.84 - $794.68 $59,542 - $66,753
84 Added 11.11%
840 $635,000
Q3 2021

Nov 10, 2021

BUY
$657.71 - $825.77 $497,228 - $624,282
756 New
756 $564,000

Others Institutions Holding BIO

About BIO-RAD LABORATORIES, INC.


  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $8.19B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Formidable Asset Management, LLC Portfolio

Follow Formidable Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Formidable Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Formidable Asset Management, LLC with notifications on news.